У нас вы можете посмотреть бесплатно Updates on non-metastatic castration-resistant prostate cancer или скачать в максимальном доступном качестве, видео которое было загружено на ютуб. Для загрузки выберите вариант из формы ниже:
Если кнопки скачивания не
загрузились
НАЖМИТЕ ЗДЕСЬ или обновите страницу
Если возникают проблемы со скачиванием видео, пожалуйста напишите в поддержку по адресу внизу
страницы.
Спасибо за использование сервиса ClipSaver.ru
Professor Kurt Miller chairs a discussion with Professor Silke Gillessen, Professor Heather Payne and Dr Eric Small on the latest data presented at the 2018 ASCO Genitourinary Cancers Symposium in San Francisco, with a focus on the treatment of patients with non-metastatic castration resistant prostate cancer (nmCRPC). Conversations focused around the SPARTAN data presented at the conference and the positive results from this trial. The group discuss their opinions around M0 patients receiving certain treatments earlier in the patient pathway, something they feel is supported by PFS2 results from SPARTAN as well as data from STAMPEDE for this patient population. The effect PSMA PET scans has had on clinical practice is also discussed. This programme has been supported by an unrestricted educational grant from Janssen Pharmaceutica (A Johnson & Johnson Company).